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Abstract
This study describes the assessment of dyspnea, symptom distress, and quality of life measures in
163 hospice patients with cancer who reported dyspnea. Mean age of the hospice patient sample
was 70.22 years and 61.86 for caregivers (65% were spouses). The majority of patients and
caregivers were white: 87%, 63% of the patients were male while 78% of caregivers were female.
Mean dyspnea intensity as reported by patients was 4.52 (SD 2.29) and caregivers, 4.39 (SD 2.93).
Patients' and caregivers' ratings of the patient's dyspnea intensity revealed no significant differences
in ratings thus verifying that caregivers can assess dyspnea severity accurately. Patients' perceived
quality of life ratings were not significantly correlated with ratings of their caregivers' perceived
quality of life. For patients, symptom distress and education were significant predictors of variance
in quality of life (R2 = .35, p = .04). However, mastery, symptom distress, age, and education were
found to be significant predictors of variance in quality of life of caregivers (R2 = .40, p = .02).
The Problem of Dyspnea and Related Symptoms 
in Hospice Patients
Respiratory symptoms are often more difficult to treat in
hospice patients with irreversible, end-stage cancer for a
number of reasons. Patients often express that these symp-
toms, dyspnea, pleural pain, and panic, are ones that they
fear the most. The National Hospice Study showed that
for patients in the last six weeks of life, dyspnea occurred
in 70% of patients.[1] Other research indicates that dysp-
nea is the fourth most common symptom of patients who
present to the emergency department with advanced can-
cer. Dyspnea is thought to be a clinical marker for the ter-
minal phase of their disease.[2] When dyspnea becomes
emergent in advanced cancer patients, it may indicate a
phase in their illness in which resources should be shifted
from acute intervention to palliative and supportive care
measures.[3]
The problems of dyspnea assessment and management
are also of clinical importance for the quality of life of
hospice patients and their families. Strategies to reduce
and manage dyspnea in hospice patients have been tested
only minimally and almost all of the studies have had in-
adequate sample sizes. Because so little is known about
the treatment of severe dyspnea, patients, health care pro-
viders, and caregivers are frustrated and left with feelings
of helplessness. It is estimated that only 20% of those suf-
fering from chronic dyspnea obtain relief through treat-
ment.[3] Moody, McCormick, and Williams found that in
patients with chronic lung disease, dyspnea severity di-
rectly affects functional status and impaired functional
status subsequently diminishes perceived quality of
life.[4]
A study by Webb, Moody, and Mason from two large hos-
pices in Florida revealed nurses' initial and ongoing
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assessments of patients with end-stage-lung disease did
not include regular use of any of the preferred dyspnea
measurement scales, such as the graphic rating scale or vis-
ual analog scale.[5] Nursing staff from the hospice study
sites expressed a need for studies that tested which clinical
interventions are most useful in alleviating dyspnea. The
aims of the present study were to examine hospice pa-
tients with cancer who suffer from dyspnea and its rela-
tion to other quality of life indicators and to describe their
caregivers' symptom-related distress, feelings of mastery,
and perceived quality of life as related to being caregivers.
Research Questions
Severe dyspnea, whether acute or chronic, affects patients'
functional status and quality of life as well as other psy-
chosocial aspects of the patient's life.[6] Patients with se-
vere dyspnea who are in hospice care most often manifest
the associated symptoms and problems of anxiety, fa-
tigue, and sleeplessness which in turn affect functional
status and cognitive status, and subsequently decrease
quality of life.[4] Based on previous studies,[4,6,7] a spe-
cific study aim was to explore the congruence of dyspnea
ratings by caregivers with patients' ratings of dyspnea. An-
other aim was to explore the relation of the patient's dys-
pnea and related variables to the patient's quality of life as
well as the effect on the caregiver's quality of life. The
study addressed three specific research questions in hos-
pice patients with end-stage lung cancer and their
caregivers.
1. Are there significant differences in the intensity ratings
of the patients' dyspnea between patients and caregivers?
2. To what extent do these patient-variables, age, educa-
tional level, dyspnea intensity, symptom distress, and
functional status, explain variance in the patient's per-
ceived quality of life?
3. To what extent do these caregiver-variables, age, educa-
tional level, dyspnea intensity, symptom distress, and
mastery, explain variance in the caregiver's perceived qual-
ity of life.
Conceptual Framework
The conceptual framework for this study was adapted
from the previous work of Moody, McCormick, and Wil-
liams who that found mastery was associated with im-
proved symptom management which leads to improved
functional status and perceived quality of life.[4] Another
underlying assumption is that accurate assessment of
symptoms leads to improved management, an assump-
tion that has yet to be tested but will be the focus of a fu-
ture study. In the present study, the perceived mastery
level of the patient was not measured but it was assessed
for the caregiver.
Nurses and physicians often fail to assess dyspnea accu-
rately, as they tend to assess only observable signs of dys-
pnea. Breathlessness, the subjective component of
dyspnea, is often different from what is directly observa-
ble.[5] Since the early 1980s, there have been a number of
tools available to measure dyspnea in acute and chronic
illness. Studies, which have measured dyspnea appropri-
ately, generally use a quantitative method of self-assess-
ment such as the visual analog scale or a graphic rating
scale. The graphic rating scale is a bipolar scale with "0"
for "No dyspnea" and "10" for Worst Dyspnea Ever." In
general, a graphic rating scale is preferred for older people,
hospice patients, and those who are apt to be easily fa-
tigued. The researchers' previous experience with the in-
strument has shown the graphic rating scale to be the best
choice for caregivers in terms of ease of use and
accuracy.[4,6]
Dyspnea and Hospice Care
In hospice patients, it is not uncommon to find acute and
chronic dyspnea because most patients have one of these
primary diagnoses: end-stage lung disease (COPD or in-
terstitial fibrosis), lung cancer, or end-stage heart dis-
ease.[7] Aggressive treatment of distressing
symptomatology contributes to overall quality of life and
restores to the patient some of the freedom and autonomy
usurped by the disease process.
Dyspnea is often associated with other common symp-
toms: fatigue, cough, anxiety, and pain.[5] This cluster of
symptoms is usually studied together, and caregivers are
often asked to assess all of them using various types of an-
alog or graphic rating scales. In planning interventions for
dyspnea, it is important to assess the degree of distress the
dyspnea causes for the patient and in turn the caregiver.
Moody and other researchers have found, that the onset of
acute dyspnea in patients who have not experienced dys-
pnea before, may cause severe anxiety in both the patient
and the caregiver.[7] In order to improve symptom man-
agement in hospice care, it is important to study whether
caregivers are able to use the assessment tools and achieve
ratings congruent with the patient's ratings.
Caregivers in Hospice Care
Until recently, most research in psychosocial oncology
and palliative care focused exclusively on the patient.
However, terminal diseases are a major stressor for both
the patient and the family caregiver, causing a new set of
challenges for both.[8] At the very least, the routine of dai-
ly life is altered and both patients and family members
must struggle to adjust and respond to new demands.[9]
Recent research suggests that family caregivers experience
depression and anxiety, psychosomatic symptoms, restric-
tions of roles and activities, strain in marital relationships,
and diminished physical health.[10] Indeed, researchHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/9
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suggests that spouses experience as much, if not more, dis-
tress than patients. [11] This emotional distress may affect
role functioning, both within the family as well as in soci-
ety including the ability to care for the patient.[12] Car-
egiver distress is an important concern because family
caregivers are assuming more responsibility for care as
treatment moves increasingly to the outpatient arena. It is
increasingly important to evaluate quality of life (QOL) of
family caregivers because of their increased responsibility
and contribution to the care of the cancer patient. Howev-
er, most studies to date have focused on specific out-
comes, such as needs, burden, and emotional distress
rather than on a more comprehensive evaluation of QOL
outcomes.
Methods
This descriptive, cross-sectional study was a substudy of a
larger NCI-funded randomized clinical trial to test an in-
tervention designed to assist caregivers in coping with
symptoms near the end of life. Baseline data from
matched hospice patients with cancer and their caregivers
are included in this analysis.
Setting and Sample
A large hospice provider in SW Florida was the site for the
overall study of 300 patient/caregiver dyads that had been
accrued at the time of this secondary analysis. This sub-
study was focused on the 162 dyads (54 percent) from the
sample, which were identified through the patient's self-
report of dyspnea at the time of admission. To be eligible,
patients had to be adults (+18 years) with a diagnosis of
cancer and an identified family caregiver who was a
spouse or adult child, and both had to consent to partici-
pate. Both had to have at least a sixth grade education, be
able to read and understand English, and pass cognitive
screening with the Short Portable Mini-mental Status
Exam [13] (Pfeiffer, 1974).
Study Instruments
Dyspnea Intensity
For hospice patients with severe dyspnea and fatigue, a bi-
polar 11-point Dyspnea Graphic Rating Intensity Scale
(DGRIS) was used.[4] This global scale, which assesses
only the perceived severity of the dyspnea, was used due
to ease of administration and accuracy. Reliability and va-
lidity of the one-item graphic rating scales have been sup-
ported by a number of studies. Scores range from 0 to 10.
Test-retest reliability has ranged from .89 to .92 and con-
current validity with other measures .88 to .94.[5] Al-
though this scale was designed for patient self-report, the
caregiver also was asked to estimate the severity of the pa-
tient's dyspnea, using this one-item scale.
Memorial Symptom Assessment Scale (MSAS)
The Memorial Symptom Assessment Scale [14] was ad-
ministered to both patients and caregivers to measure
both the frequency and distress of common symptoms ex-
perienced by patients. For patients, it was used to measure
distress caused by 24 symptoms commonly seen in per-
sons with advanced cancer, including shortness of breath.
The MSAS is a self-report scale that provides data about
the occurrence of each symptom and the distress associat-
ed with these symptoms. Distress is measured on a 5 point
summated rating scale with scores that may range from 0
(no distress) to 96 (very much distress). Validity was sup-
ported by high correlations with clinical status and quality
of life. Internal consistency was assessed using Cronbach's
alpha and found to be high, ranging from r = .83 to
.88.[15,16]
The MSAS scale was administered to all caregivers. It was
altered slightly by rewording items to determine the de-
gree to which each symptom experienced by the patient
caused distress for the caregiver. These scores also ranged
from 0 to 96. This approach has been used previously in
studies with caregivers who have dementia. [15]
Hospice Quality of Life Index
The Hospice Quality of Life Index (HQLI) is a 28-item
self-report tool that includes three aspects of overall qual-
ity of life: Psychophysiologic Well-being; Functional Well-
being; and Social and Spiritual Well-being.[16] Total
scores may range from a low of zero to a high of 280. Ev-
idence of validity and reliability of the HQLI was generat-
ed by a recently completed study.[16] Evidence of validity
was provided by the ability of the HQLI to differentiate
between hospice patients and apparently healthy controls
using both discriminate analysis (p = .00) and compari-
son of means (p = .00). Previously, the HQLI has been val-
idated for use with hospice patients with cancer. The
finding that HQLI scores correlated at the expected level (r
= .26; p = .00) with functional status scores provides fur-
ther evidence of validity. Finally, factor analysis con-
firmed the factor structure of the HQLI. Reliability of the
HQLI was provided by generation of coefficient alphas for
both total scale scores and subscale scores. Subscale al-
phas all were .84 and the total scale alpha was high for
both cancer (r = .88) and AIDS (r = .93) patients. For this
paper, the item asking the patient how breathless he or
she feels (0–10) was analyzed separately.
Mastery (Self-Efficacy) was assessed by a six-item sum-
mated rating scale with a five-point scale ranging from
"None (0)" to "A Great Deal (5)". Scores may range from
0 to 30. It was modified for the study to include content-
specific stems based on the context of caregiving and the
caregiver's perceived ability to cope with caregiving tasks
and manage day-to-day problems. The mastery scale hasHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/9
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been used by Moody, et al. in a number of dyspnea and
quality of life studies.[4,5] Reliability of the scale has
ranged from .88 to .94. Content validity and concurrent
validity have ranged from .94 to.96.[4,5]
Palliative Performance Status (PPS) Scale
The purpose of the Palliative Performance Scale (PPS) is
to assess the physical condition and functional status of
persons receiving palliative care.[17] Scores may range
from 0 (dead) to 100 (normal functioning). It is a relative-
ly new tool based on the Karnofsky Performance Scale and
is purported to provide a framework for measuring the
progressive decline in palliative care patients. The PPS
measures three broad areas of function: intake, level of
consciousness, and mobility. The PPS is scored from 0–
100% at 10% increments. The PPS level for a given patient
is determined by reading across the table at each 10% dec-
rement to find the overall best fit. 'Stronger' performance
factors are noted to be located on the left of the instru-
ment 'softer' ones on the right. Judgment is required if one
of the five factors observed in a particular patient does not
fit with the others. The usual approach to decide PPS is to
first determine whether the disease has limited the ability
to work or ambulate (left side), and then work one's way
across the table. Patients who have a lower PPS generally
are more functionally impaired than those with higher
scores. Prognosis is generally related to functional status
in most palliative care patients. Those patients with higher
PPS scores may have longer length of stays, although all
patients may not be comparable. Progression of disease
can generally be noted with declining PPS levels in a given
patient. Interpretation of the instrument may have impli-
cations about patient acuity and need for amount of
services.
The initial validity study assessed 119 patients at home
and 213 patients admitted to a hospice unit. Validity of
this instrument was assessed comparing the PPS score
with length of survival. The average period until death for
129 patients who died on the unit was 1.88 days at 10%
PPS on admission, 2.62 days at 20%, 6.7 days at 30%,
10.3 at 40%, 13.87 at 50%. Only two patients at 60% or
higher died in the unit. As part of an earlier project we as-
sessed validity and reliability of the PPS. The predicted
strong positive correlations between PPS and KFS (r = .88,
p = .01) support construct (convergent) validity.[17] Al-
though no reliability data were reported by the tool devel-
opers, the researchers in this substudy found that inter-
rater reliability was very strong (r = .95. p = .01, df 162).
Demographic Data
Standard demographic data were collected on dyads to al-
low description of the sample. Patient data included age,
gender, education level, marital status, religion, occupa-
tion, cancer diagnosis, and length of time since diagnosis.
Data on caregivers were assessed by self-report in a semi-
structured interview: age, ethnicity, gender, education,
marital status, and religion.
Study Procedures
This study was approved by the bioethics committees of
the hospice. Following approval by this committee, the
proposal was approved by the University of South Florida
Institutional Review Board for the Protection of Human
Subjects. Eligible dyads that were potential study subjects
were initially identified by hospice admission staff and re-
ferred to the Research Assistant (RA), a trained nursing
data collector, at the beginning of each day. The RA con-
tacted the caregiver to arrange a visit by both the nurse and
a Home Health Aide (HHA). During this visit, the study
was explained, consent of both patient and caregiver ob-
tained, the mental status of the caregiver assessed, and the
functional status of the patient evaluated. Patients and
caregivers who met the admission criteria were asked to
complete their respective questionnaires independently,
in separate rooms when possible. The HHA collected pa-
tient data and stayed with the patient to assist as needed.
The HHA reassured the caregiver that the patient would
not be alone while the RA was collecting data from the pa-
tient. Therefore, the caregiver was better able to concen-
trate on the questionnaires knowing that the HHA was
with the patient.
Data Analysis
Data for all demographic variables and study variables
were analyzed first using descriptive statistics with SPSS
version 11.5.[18] Multiple correlation and paired t-tests
were used to analyze significant differences in ratings be-
tween caregivers and patients and associations between
related symptoms and conditions. Stepwise multiple re-
gression models were used to address research questions
two and three.
Results
Profile of Study Patients and Caregivers
Usable data were collected on 163 hospice patients/car-
egiver-dyads. A profile of the study group is included in
Table 1. The mean age of the hospice patient was 70.22
years and 61.86 for caregivers. About 30 % of caregivers
were adult children and the majority was spouses. The
dyad majority was white, 85%, 11% African-American,
6% Hispanic, and 1% Asian. The majority of patients were
male, 63%, while 74% of caregivers were female. There
were no mean differences in cognitive status (SPMSQ)
scores between caregivers and patients. The education lev-
el of patients was 12.1 years compared to 12.8 for caregiv-
ers. Eighty percent of dyad-participants had annual
incomes of less than $50,000. Of the patient sample,
about 40 percent had lung cancer, 14 percent colon can-
cer, 6 percent breast cancer, 6 percent prostate, and 34%Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/9
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other types of cancer. Of the caregivers, 75% reported one
or more medical problems and 15% reported a mental
health problem, mostly depression.
Dyspnea Ratings and Overall Symptom Distress (MSAS)
Mean dyspnea ratings as reported by the patients was 4.52
(SD 2.29) and by the caregivers was 4.39 (SD 2.93). To ad-
dress research question one, a paired, two-tailed t-test was
used to assess if there were significant differences between
caregivers-patient dyad ratings of the patient's dyspnea in-
tensity. As shown in the boxplot in Figure 1, results indi-
cated that the distribution of scores and means were
almost identical (Mean difference = .-13, t = -.53, df 162,
p = .59). Paired, bivariate correlation was used to deter-
mine the relationship between patient and caregiver rat-
ings of dyspnea. The correlation between patient and
caregiver scores was weak but significant (r = .33; p = .000,
df 1, 162).
Patients' mean score on the MSAS symptom distress scale
(Table 1), which includes 24 common symptoms experi-
enced by hospice patients, including dyspnea were rated
at about the same level. Mean score of caregivers was
25.41, compared to that of patients, 25.60.
Factors Influencing Patients' Quality of Life
To address the second research question, a stepwise mul-
tiple regression was used to determine if these patient-var-
iables, age, educational level, symptom distress (MSAS),
dyspnea intensity, and functional status (PPS), explained
variance in the dependent variable, patient's perceived
quality of life (HRQL). Variables were entered into the
model stepwise with quality of life as the dependent vari-
able (Table 2). All variables were entered into the model
except for age, dyspnea intensity, and functional status.
Regression results indicated that symptom distress and ed-
ucation were the only significant predictors of the pa-
tient's quality of life (R2 = .35, p = .04).
Factors Influencing Caregivers' Quality of Life
The third research question was examined using stepwise
multiple regression to determine if the caregiver's per-
ceived levels of mastery, symptom distress, age, educa-
tional level, and the patient's dyspnea intensity were
significantly related to their perceived quality of life. All
variables were entered into the model with quality of life
as the dependent variable. Results showed that three vari-
ables were significant predictors of variance in the caregiv-
ers' quality of life (R2 = .40, p = .02): mastery, symptom
distress, age, and education (Table 2).
Discussion
Dyad ratings of the patients' dyspnea were almost identi-
cal (paired mean difference was -0.13). These findings
support other researchers such as those of Sneeuw and
colleagues [21] who found that, with few exceptions,
Table 1: Demographic Profile and Baseline Symptom Data for Hospice Patients and Their Caregivers
Baseline Patient Variables f % Range Mean SD
Male Female 102 61 63 37
White Non-white 141 22 87 13
Cough with Dyspnea 106 64
Age 37.79 to 91.79 70.22 10.96
Educational Level 1 to 25 12.15 3.36
Months Since Diagnosis 1 to 360 27.55 50.32
Dyspnea Intensity 3 to 10 4.52a 2.29
Symptom Distress (MSAS) 2 to 76 25.60 1.52
Health Related Quality of Life 137 to 278 208.81 35.57
Palliative Performance Scale 30 to 100 53.52 .79
Baseline Caregiver Variables f % Range Mean SD
Female Male 127 35 78 22
White Nonwhite 143 20 88 12
Age 26.02 to 91.90 61.86 14.46
Caregiver Variables (con't) Range Mean SD
Educational Level 4 to 22 12.82 2.73
Mastery Level 10 to 42 25.02 4.84
Symptom Distress (MSAS) 10 to 112 25.41 12.61
Health Related Quality of Life 11 to 116 55.06 22.10
Rating of Patients' Dyspnea 2 to 9 4.39a 2.93
a: Significant correlation between 
tings: Pearson r = .33, p = .000, df 161)Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/9
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Figure 1
Table 2: Stepwise Regression Models: Patient and Caregiver Predictors of Quality of Life
Patient Modela Predictors B SE Beta Lower CI Upper CI t df p-value
Symptom distress (MSAS) -1.57 .17 -.58 -1.91 -1.23 -9.09 2, 160 .000
Education -1.32 .64 -.13 -2.58 -.06 -2.07 .040
Caregiver Modelb Predictors B SE Beta Lower CI Upper CI t df p-value
Mastery -2.16 .30 -.47 -2.75 -1.57 -7.24 3, 156 .000
Symptom distress (MSAS) .67 .15 .28 .37 .98 4.34 .000
Age -.32 .10 -.20 -.51 -.12 -3.16 .002
Education 1.16 .51 .14 .14 .16 2.16 .023
a: Al lpredictor variables entered stepwise: dyspnea intensity, age, and functional status removed. Dependent variable: Patient Quality of Life b: All 
predictor variables entered stepwise: dyspnea intensity removed. Dependent variable: Caregiver Quality of LifeHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/9
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mean scores of the proxy raters were equivalent to those
of the patient, varying between 0.40 and 0.60, indicating
a moderate level of agreement at the individual level. Dis-
agreement was not dependent on the type of proxy rater,
or on raters' background characteristics, but was influ-
enced by the QOL dimension under consideration and
the clinical status of the patient.[21] Although our find-
ings also confirm that patient-caregiver dyspnea ratings
were not significantly different (mean difference -0.19),
the correlation between caregiver-patient ratings were sig-
nificant but relatively not that strong (r .33, p = .000, df 1,
162). Data were checked twice for accuracy, reanalyzed,
and the results were identical. Why the correlation is not
stronger in view of the negligible mean difference in
paired-dyad ratings is puzzling. The results indicate that
both significant others and health care providers can be
useful sources of information about cancer patients' QOL.
Measurement of dyspnea needs to be done frequently us-
ing standardized instruments, such as the one-item,
graphic rating scale to assess dyspnea and effects of
treatments.
Results of the regression analysis revealed that the pa-
tient's perceived symptom distress and educational level
are the most important variables that explain variance in
their quality of life. This finding is similar to a previous
study by Moody, McCormick, and Williams.[4] These re-
sults confirm the importance of assessing and managing
the symptoms to improve or maintain quality of life.
Conclusions
From the results, it is clear that caregivers can obtain rat-
ings of dyspnea that are congruent with the patient's per-
ceived symptoms. This is especially important in hospice
care as patients may become so debilitated that they need
to rely on proxy ratings from their caregivers to assess and
attend to their symptom management Caregiver perceived
quality of life was related to four variables, perceived mas-
tery, symptom distress, age, and years of education, with
mastery being the strongest predictor. Overall symptom
distress and education were found to be the best predic-
tors of the patient's quality of life. In the current study,
mastery was tested only in the caregivers. However,
Moody and colleagues found mastery to be an important
predictor of the patient's quality of life and recommend it
be assessed in both patient and caregiver.[4]
Future research in the form of clinical trials is needed to
test interventions to manage the severe dyspnea and relat-
ed symptoms that occur in patients with cancer and end-
stage lung disease. Therapies for dyspnea in the hospice
setting have been subjected to only minimal scientific
study, especially for end-stage chronic obstructive lung
disease and lung cancer. Evidence-based clinical guide-
lines such as those developed for pain management are
needed for dyspnea assessment and improved manage-
ment of symptoms.
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